Signaturefd LLC Sells 224 Shares of Innospec Inc. (NASDAQ:IOSP)

Signaturefd LLC lessened its position in shares of Innospec Inc. (NASDAQ:IOSPFree Report) by 19.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 944 shares of the specialty chemicals company’s stock after selling 224 shares during the quarter. Signaturefd LLC’s holdings in Innospec were worth $116,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of IOSP. GSA Capital Partners LLP purchased a new position in Innospec during the third quarter worth $1,978,000. Bahl & Gaynor Inc. grew its holdings in Innospec by 112.1% during the 3rd quarter. Bahl & Gaynor Inc. now owns 34,824 shares of the specialty chemicals company’s stock valued at $3,559,000 after purchasing an additional 18,407 shares during the last quarter. Acadian Asset Management LLC raised its position in Innospec by 19.7% in the 3rd quarter. Acadian Asset Management LLC now owns 111,652 shares of the specialty chemicals company’s stock worth $11,393,000 after purchasing an additional 18,371 shares during the period. Illinois Municipal Retirement Fund bought a new stake in Innospec in the third quarter worth about $1,490,000. Finally, Louisiana State Employees Retirement System purchased a new position in shares of Innospec during the fourth quarter valued at approximately $1,528,000. 96.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Innospec news, SVP Hardy Louis Griffin III sold 1,875 shares of the stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total value of $228,881.25. Following the completion of the sale, the senior vice president now directly owns 5,000 shares in the company, valued at $610,350. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Innospec news, SVP Hardy Louis Griffin III sold 1,875 shares of the company’s stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $122.07, for a total transaction of $228,881.25. Following the transaction, the senior vice president now owns 5,000 shares in the company, valued at approximately $610,350. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Williams sold 9,667 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $124.37, for a total transaction of $1,202,284.79. Following the sale, the chief executive officer now directly owns 174,334 shares in the company, valued at $21,681,919.58. The disclosure for this sale can be found here. Insiders have sold a total of 36,500 shares of company stock worth $4,532,959 in the last ninety days. 1.35% of the stock is owned by insiders.

Innospec Stock Performance

IOSP stock opened at $121.19 on Tuesday. The firm has a market cap of $3.02 billion, a price-to-earnings ratio of 21.76 and a beta of 1.10. The firm has a 50-day simple moving average of $124.22 and a two-hundred day simple moving average of $116.26. Innospec Inc. has a one year low of $91.74 and a one year high of $131.18.

Innospec (NASDAQ:IOSPGet Free Report) last announced its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.25. The company had revenue of $494.70 million during the quarter, compared to the consensus estimate of $479.47 million. Innospec had a net margin of 7.14% and a return on equity of 13.69%. Innospec’s revenue was down 3.1% compared to the same quarter last year. During the same period last year, the firm earned $1.20 earnings per share. As a group, equities analysts predict that Innospec Inc. will post 6.77 earnings per share for the current fiscal year.

Innospec Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Stories

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.